Smoking Cessation in Workplaces in Hong Kong [Phase II]
1 novembre 2016 mis à jour par: The University of Hong Kong
Assessing the Corporate Environment in Promoting Tobacco Control and Evaluation of a Smoking Cessation Programme in Workplaces in Hong Kong
This study has the following objectives:
- To examine the employers'/managerial staff's knowledge, attitudes and practices in promoting smoking cessation in workplace.
- To evaluate the smoking behaviours of participants before and after attending a smoking cessation intervention.
Aperçu de l'étude
Statut
Inconnue
Les conditions
Description détaillée
Study design In Phase I of this study, a large scale cross-sectional survey will be sent to 3000 corporations in Hong Kong. The questionnaire will examine the employers' knowledge, attitudes and practices in promoting smoking cessation in the workplace.
In Phase II, a longitudinal study will be conducted to evaluate the effectiveness of a smoking cessation intervention offered by the Department of Psychology, the University of Hong Kong. A total of 600 smokers from corporations will be recruited and interviewed before the intervention at baseline, immediately after the intervention, and at 1-, 4-, 12-, 26- and 52-week post-intervention follow-ups, in an attempt to evaluate their smoking behaviours, knowledge on smoking and satisfaction of the smoking cessation services. Self-reported quitters (did not smoke in the past 7 days) will be invited to participate in the bio-chemical validation by assessing their exhaled carbon monoxide level and the saliva cotinine level.
Process evaluation: Qualitative interviews, including in-depth interviews and/or focus group will be conducted within 1 month after 12-month follow-up.
Type d'étude
Interventionnel
Inscription (Anticipé)
600
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Hong Kong, Chine
- 2/F, 61 Lung Kong Rd, Kowloon City, Lok Sin Tong Benevolent Society
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans et plus (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- Hong Kong residents aged 18 or above
- Cantonese speaker and able to read in Chinese characters
- Smoke at least one cigarette per day
- Stay at Hong Kong during the intervention and follow-up periods (12 months)
Exclusion Criteria:
- Smokers who are psychologically or physically unable to communicate
- Smokers who are currently following other smoking cessation programme(s)
- Smokers with diagnosed psychiatric illnesses
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Non randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Group A
Health talk + workshop (Motivational intervention) + booklet + Short Message Service (SMS)
|
Through intensive workshop which includes motivation of quitting enhancement, stress management, smoking triggers, cravings and relapse, to provide smoking cessation intervention
Health talk provided information about hazards of tobacco (active smoking, second- and third-hand smoke), benefits of quitting smoking and methods to quit smoking
Use motivational interview strategies through telephone messages to provide smoking cessation intervention
A 26-page booklet included information about smoking and diseases, benefits of quitting smoking, methods to quit smoking, how to handle withdrawal symptoms, stress management, declaration of quitting smoking, decisional balance of smoking or quitting
|
|
Comparateur placebo: Group B
Face to Face counseling (Motivational intervention) + Booklet + SMS
|
Health talk provided information about hazards of tobacco (active smoking, second- and third-hand smoke), benefits of quitting smoking and methods to quit smoking
Use motivational interview strategies through telephone messages to provide smoking cessation intervention
A 26-page booklet included information about smoking and diseases, benefits of quitting smoking, methods to quit smoking, how to handle withdrawal symptoms, stress management, declaration of quitting smoking, decisional balance of smoking or quitting
Use motivational interview strategies through face-to-face counseling to provide smoking cessation intervention
|
|
Comparateur placebo: Group C
Phone counseling (Motivational intervention) + Health talk + booklet + SMS
|
Health talk provided information about hazards of tobacco (active smoking, second- and third-hand smoke), benefits of quitting smoking and methods to quit smoking
Use motivational interview strategies through telephone messages to provide smoking cessation intervention
A 26-page booklet included information about smoking and diseases, benefits of quitting smoking, methods to quit smoking, how to handle withdrawal symptoms, stress management, declaration of quitting smoking, decisional balance of smoking or quitting
|
|
Comparateur placebo: Group D
Phone counseling (Motivational intervention) + booklet + SMS
|
Use motivational interview strategies through telephone messages to provide smoking cessation intervention
A 26-page booklet included information about smoking and diseases, benefits of quitting smoking, methods to quit smoking, how to handle withdrawal symptoms, stress management, declaration of quitting smoking, decisional balance of smoking or quitting
Use motivational interview strategies through telephone counseling to provide smoking cessation intervention
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change from baseline smoking quit rate at 6-month
Délai: 6 months after the intervention
|
Quit smoking rate is defined by the self-reported 7-day point prevalence abstinence.
It is a binary type (yes/no) questionnaire and participants answer the question about their smoking status in the past 7 days at 6-month after the intervention.
|
6 months after the intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change from baseline smoking reduction at 6-month
Délai: 6 months after the intervention
|
Smoking reduction is defined as reduced at least 50% of cigarette consumption.
Participants were asked to respond to the daily cigarette consumption at 6-month after the intervention.
Their daily cigarette consumption at 6-month were compared with baseline's daily cigarette consumption and determine whether they had reduced at least 50% cigarette consumption at 6-month.
|
6 months after the intervention
|
|
Change from baseline smoking reduction at 12-month
Délai: 12 months after the intervention
|
Smoking reduction is defined as reduced at least 50% of cigarette consumption.
Participants were asked to respond to the daily cigarette consumption at 6-month after the intervention.
Their daily cigarette consumption at 12-month were compared with baseline's daily cigarette consumption and determine whether they had reduced at least 50% cigarette consumption at 12-month.
|
12 months after the intervention
|
|
Change from baseline smoking quit rate at 12-month
Délai: 12 months after the intervention
|
Quit smoking rate is defined by the self-reported 7-day point prevalence abstinence.
It is a binary type (yes/no) questionnaire and participants answer the question about their smoking status in the past 7 days at 12-month after the intervention.
|
12 months after the intervention
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Man-ping Wang, PhD, School of Nursing, The University of Hong Kong
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 janvier 2015
Achèvement primaire (Anticipé)
1 juin 2017
Achèvement de l'étude (Anticipé)
1 juin 2017
Dates d'inscription aux études
Première soumission
9 juillet 2015
Première soumission répondant aux critères de contrôle qualité
15 janvier 2016
Première publication (Estimation)
20 janvier 2016
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
3 novembre 2016
Dernière mise à jour soumise répondant aux critères de contrôle qualité
1 novembre 2016
Dernière vérification
1 novembre 2016
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- LSTWPLACE2015
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .